On the final point, it is of course my expectation that the Stroke Association, in work in partnership with the NHS family, will be putting forward the sort of measures they want to see. That's whole point about having them engaged in the conversation, to make sure they can put forward their perspective and we end up with something that is useful as opposed to simply yet another process measure that doesn't tell people much of value at all. We've managed to have lots of process measures in and around the healthcare system and I'm keen that we don't introduce another process measure that counts volume or activity but doesn't tell us something useful. 

On your other point about comparing like for like, I can confirm we are comparing like with like. We're looking at the volume of calls, and in particular on the amber category it's worth noting that in April of this year we had 10 per cent more calls in the month of April than April the last year. So, actually there's a significant amount of activity that is taking place and that definitely affects calls within the amber category. 

In terms of the point about response from the four care homes, I asked about this particular question before making the statement, about why four care homes had not, and it's simply a matter of contact—so, the Welsh ambulance service trust have contacted and made it clear that the offer is available for those care homes that don't have modern, up-to-date lifting equipment, and it's simply about the response from those homes. But the Welsh ambulance service trust have not given up and they continue to try to make contact with those homes. If we could then say we have complete coverage that would be a very positive thing to say. But, within the care homes within Wales, to only have four is in itself a significant marker of achievement. 

And on, I think, your final point of the four points that I thought you asked about, in terms of patient experience, it's something the chief ambulance service commissioner is really interested in, in understanding, in all the measures that he's taken on board since we introduced the new clinical response model, the richness of the data that's available to understand not just the impact of the work that our staff do on outcomes and experience but then to make sure you're properly capturing the patient experience itself. So, yes, you can expect to see that, and I expect when the programme board's time of life comes to an end we'll understand more about what people who have received the service and taken part in the service actually think whether they've been transported to another place to have healthcare delivered, or indeed whether they've been able to do that in their own homes.